These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31337831)
41. What planar lipid membranes tell us about the pore-forming activity of cholesterol-dependent cytolysins. Marchioretto M; Podobnik M; Dalla Serra M; Anderluh G Biophys Chem; 2013 Dec; 182():64-70. PubMed ID: 23876488 [TBL] [Abstract][Full Text] [Related]
42. Formation of hybrid bilayers on silanized thin-film Ti electrode. Valiūnienė A; Petrulionienė T; Balevičiūtė I; Mikoliūnaitė L; Valinčius G Chem Phys Lipids; 2017 Jan; 202():62-68. PubMed ID: 27964891 [TBL] [Abstract][Full Text] [Related]
43. Ionic factors regulating the interaction of Gardnerella vaginalis hemolysin with red blood cells. Cauci S; Monte R; Quadrifoglio F; Ropele M; Menestrina G Biochim Biophys Acta; 1993 Nov; 1153(1):53-8. PubMed ID: 8241250 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and characterization of tethered lipid assemblies for membrane protein reconstitution (Review). Veneziano R; Rossi C; Chenal A; Brenner C; Ladant D; Chopineau J Biointerphases; 2017 Sep; 12(4):04E301. PubMed ID: 28958150 [TBL] [Abstract][Full Text] [Related]
45. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model. Breshears LM; Edwards VL; Ravel J; Peterson ML BMC Microbiol; 2015 Dec; 15():276. PubMed ID: 26652855 [TBL] [Abstract][Full Text] [Related]
46. Cervical cancer and vaginal microbiota changes. Kovachev SM Arch Microbiol; 2020 Mar; 202(2):323-327. PubMed ID: 31659380 [TBL] [Abstract][Full Text] [Related]
47. Vaginal dysbiotic bacteria act as pathobionts of the protozoal pathogen Trichomonas vaginalis. Hinderfeld AS; Simoes-Barbosa A Microb Pathog; 2020 Jan; 138():103820. PubMed ID: 31669328 [TBL] [Abstract][Full Text] [Related]
48. Gardnerella vaginalis and Lactobacillus sp in liquid-based cervical samples in healthy and disturbed vaginal flora using cultivation-independent methods. Klomp JM; Verbruggen BS; Korporaal H; Boon ME; de Jong P; Kramer GC; van Haaften M; Heintz AP Diagn Cytopathol; 2008 May; 36(5):277-84. PubMed ID: 18418885 [TBL] [Abstract][Full Text] [Related]
49. Sensing of pathogenic bacteria based on their interaction with supported bilayer membranes studied by impedance spectroscopy and surface plasmon resonance. Tun TN; Cameron PJ; Jenkins AT Biosens Bioelectron; 2011 Oct; 28(1):227-31. PubMed ID: 21835605 [TBL] [Abstract][Full Text] [Related]
50. Antimicrobial susceptibility and vaginolysin in Gardnerella vaginalis from healthy and bacterial vaginosis diagnosed women. Knupp de Souza DM; Diniz CG; Filho DS; Andrade de Oliveira LM; Coelho DM; Talha LS; Nascimento TC; Ferreira-Machado AB; Silva VL J Infect Dev Ctries; 2016 Sep; 10(9):913-919. PubMed ID: 27694723 [TBL] [Abstract][Full Text] [Related]
52. Resolution and Cooccurrence Patterns of Gardnerella leopoldii, G. swidsinskii, G. piotii, and G. vaginalis within the Vaginal Microbiome. Hill JE; Albert AYK; Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527125 [No Abstract] [Full Text] [Related]
53. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Tachedjian G; Aldunate M; Bradshaw CS; Cone RA Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139 [TBL] [Abstract][Full Text] [Related]
54. A molecular toolkit for highly insulating tethered bilayer lipid membranes on various substrates. Atanasov V; Atanasova PP; Vockenroth IK; Knorr N; Köper I Bioconjug Chem; 2006; 17(3):631-7. PubMed ID: 16704200 [TBL] [Abstract][Full Text] [Related]
55. Vaginal Dysbiosis from an Evolutionary Perspective. Schlabritz-Loutsevitch N; Gygax SE; Dick E; Smith WL; Snider C; Hubbard G; Ventolini G Sci Rep; 2016 May; 6():26817. PubMed ID: 27226349 [TBL] [Abstract][Full Text] [Related]
56. Rapid impedance measurement of tethered bilayer lipid membrane biosensors. Mu X; Rairigh D; Liu X; Mason AJ Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():4796-9. PubMed ID: 22255411 [TBL] [Abstract][Full Text] [Related]
57. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. Mastromarino P; Brigidi P; Macchia S; Maggi L; Pirovano F; Trinchieri V; Conte U; Matteuzzi D J Appl Microbiol; 2002; 93(5):884-93. PubMed ID: 12392537 [TBL] [Abstract][Full Text] [Related]
58. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. Atassi F; Brassart D; Grob P; Graf F; Servin AL FEMS Immunol Med Microbiol; 2006 Dec; 48(3):424-32. PubMed ID: 17059467 [TBL] [Abstract][Full Text] [Related]
59. Lactobacillus johnsonii HY7042 ameliorates Gardnerella vaginalis-induced vaginosis by killing Gardnerella vaginalis and inhibiting NF-κB activation. Joo HM; Hyun YJ; Myoung KS; Ahn YT; Lee JH; Huh CS; Han MJ; Kim DH Int Immunopharmacol; 2011 Nov; 11(11):1758-65. PubMed ID: 21798373 [TBL] [Abstract][Full Text] [Related]
60. Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota. Collins SL; McMillan A; Seney S; van der Veer C; Kort R; Sumarah MW; Reid G Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]